These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21821570)

  • 1. Setting cost-effectiveness thresholds as a means to achieve appropriate drug prices in rich and poor countries.
    Danzon PM; Towse A; Mulcahy AW
    Health Aff (Millwood); 2011 Aug; 30(8):1529-38. PubMed ID: 21821570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-being.
    Lichtenberg FR
    Health Aff (Millwood); 2011 Aug; 30(8):1539-44. PubMed ID: 21821571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk sharing methods in middle income countries].
    Inotai A; Kaló Z
    Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug makers to cut prices for developing countries.
    AIDS Alert; 1998 Aug; 13(8 Suppl):1-2. PubMed ID: 11365655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value-based differential pricing: efficient prices for drugs in a global context.
    Danzon P; Towse A; Mestre-Ferrandiz J
    Health Econ; 2015 Mar; 24(3):294-301. PubMed ID: 24327269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The level of income appears to have no consistent bearing on pharmaceutical prices across countries.
    Morel CM; McGuire A; Mossialos E
    Health Aff (Millwood); 2011 Aug; 30(8):1545-52. PubMed ID: 21821572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prices of pharmaceuticals in poor countries are much lower than in wealthy countries.
    Schweitzer SO; Comanor WS
    Health Aff (Millwood); 2011 Aug; 30(8):1553-61. PubMed ID: 21821573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug pricing and value in oncology.
    Danzon PM; Taylor E
    Oncologist; 2010; 15 Suppl 1():24-31. PubMed ID: 20237214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of branded prescription medicine prices in OECD countries.
    Kanavos PG; Vandoros S
    Health Econ Policy Law; 2011 Jul; 6(3):337-67. PubMed ID: 21676345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affordably priced new drugs for poor populations: Approaches for a global solution.
    Mossialos E; Dukes G
    Int J Risk Saf Med; 2001; 14(1):1-29. PubMed ID: 22388482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health economics in developing countries.
    Abel-Smith B
    J Trop Med Hyg; 1989 Aug; 92(4):229-41. PubMed ID: 2503621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential pricing for pharmaceuticals: reconciling access, R&D and patents.
    Danzon PM; Towse A
    Int J Health Care Finance Econ; 2003 Sep; 3(3):183-205. PubMed ID: 14625999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent analgesics are more expensive for patients in developing countries: a comparative study.
    De Lima L; Sweeney C; Palmer JL; Bruera E
    J Pain Palliat Care Pharmacother; 2004; 18(1):59-70. PubMed ID: 15148009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Price differentiation and transparency in the global pharmaceutical marketplace.
    Ridley DB
    Pharmacoeconomics; 2005; 23(7):651-8. PubMed ID: 15987224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of a value based pricing index for new drugs in metastatic colorectal cancer.
    Dranitsaris G; Truter I; Lubbe MS
    Eur J Cancer; 2011 Jun; 47(9):1299-304. PubMed ID: 21493060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International differences in drug prices.
    Wagner JL; McCarthy E
    Annu Rev Public Health; 2004; 25():475-95. PubMed ID: 15015931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How private, voluntary health insurance can work in developing countries.
    Pauly MV; Blavin FE; Meghan S
    Health Aff (Millwood); 2009; 28(6):1778-87. PubMed ID: 19887419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of health insurance coverage in women's access to prescription medicines.
    Ranji UR; Wyn R; Salganicoff A; Yu H
    Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.